Opioid Dose Reductions by Sex and Race in a Cohort of Patients in a Family Medicine Clinic

References

1. 1.↵
   1. Dowell D,
   2. Haegerich TM,
   3. Chou R

   . CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 2016;315:1624–45.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Hulen E,
   2. Saha S,
   3. Morasco BJ,
   4. Zeigler C,
   5. Mackey K,
   6. Edwards ST

   . Sources of distress in primary care opioid management and the role of a controlled substance review group: a qualitative study. Pain Medicine 2018;19:1570–7.

   OpenUrl
3. 3.↵
   1. Zeigler C,
   2. Mackey K,
   3. Hulen E,
   4. Carr T,
   5. Saha S,
   6. Edwards ST

   . Frontline account: reducing the stress of pain management through the implementation of a controlled substance review group in a VA internal medicine residency clinic. J Gen Intern Med 2017;32:832–5.

   OpenUrl
4. 4.
   1. Seal K,
   2. Becker W,
   3. Tighe J,
   4. Li Y,
   5. Rife T

   . Managing chronic pain in primary care: it really does take a village. J Gen Intern Med 2017;32:931–4.

   OpenUrlCrossRef
5. 5.↵
   1. Awadallah N,
   2. Rollins V,
   3. Oung A,
   4. et al

   . An interprofessional approach to chronic pain management and education. Fam Med 2022;54:47–53.

   OpenUrl
6. 6.↵
   1. Rambachan A,
   2. Fang MC,
   3. Prasad P,
   4. Iverson N

   . Racial and ethnic disparities in discharge opioid prescribing from a hospital medicine service. Journal of Hospital Medicine 2021;16:589–95.

   OpenUrl
7. 7.↵
   1. Green CR,
   2. Anderson KO,
   3. Baker TA,
   4. et al

   . The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 2003;4:277–94.

   OpenUrl
8. 8.↵
   1. Dickason RM,
   2. Chauhan V,
   3. Mor A,
   4. et al

   . Racial differences in opiate administration for pain relief at an academic emergency department. WestJEM 2015;16:372–80.

   OpenUrl
9. 9.↵
   1. Hoffman KM,
   2. Trawalter S,
   3. Axt JR,
   4. Oliver MN

   . Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between Blacks and Whites. Proc Natl Acad Sci USA 2016;113:4296–301.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Lossio-Ventura JA,
    2. Song W,
    3. Sainlaire M,
    4. Dykes PC,
    5. Hernandez-Boussard T

    . Opioid2MME: standardizing opioid prescriptions to morphine milligram equivalents from electronic health records. International Journal of Medical Informatics 2022;162:104739.

    OpenUrl
11. 11.↵
    1. Crenshaw KW

    . Mapping the margins: intersectionality, identity politics, and violence against women of color. The public nature of private violence. Routledge; 2013:93–118.
12. 12.↵
    1. Jackson JW,
    2. Williams DR,
    3. VanderWeele TJ

    . Disparities at the intersection of marginalized groups. Soc Psychiatry Psychiatr Epidemiol 2016;51:1349–59.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Leece P,
    2. Buchman DZ,
    3. Hamilton M,
    4. et al

    . Improving opioid safety practices in primary care: protocol for the development and evaluation of a multifaceted, theory-informed pilot intervention for healthcare providers. BMJ open 2017;7:e013244.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Jordan M,
    2. Latif A,
    3. Mullan J,
    4. Chen TF

    . Opioid medicines management in primary care settings: a scoping review of quantitative studies of pharmacist activities. Br J Clinical Pharma 2021;87:4504–33.

    OpenUrl
15. 15.↵
    1. Buonora M,
    2. Perez HR,
    3. Heo M,
    4. Cunningham CO,
    5. Starrels JL

    . Race and gender are associated with opioid dose reduction among patients on chronic opioid therapy. Pain Medicine 2019;20:1519–27.

    OpenUrl
16. 16.↵
    1. Bauer SR,
    2. Hitchner L,
    3. Harrison H,
    4. Gerstenberger J,
    5. Steiger S

    . Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting. Substance Abuse 2016;37:110–7.

    OpenUrl
17. 17.↵
    1. Morasco BJ,
    2. Duckart JP,
    3. Carr TP,
    4. Deyo RA,
    5. Dobscha SK

    . Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. PAIN 2010;151:625–32.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Haq N,
    2. McMahan VM,
    3. Torres A,
    4. et al

    . Race, pain, and opioids among patients with chronic pain in a safety-net health system. Drug and Alcohol Dependence 2021;222:108671.

    OpenUrl
19. 19.↵
    1. Pisanu C,
    2. Franconi F,
    3. Gessa GL,
    4. et al

    . Sex differences in the response to opioids for pain relief: a systematic review and meta-analysis. Pharmacological Research 2019;148:104447.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Sharp JL,
    2. Pearson T,
    3. Smith MA

    . Sex differences in opioid receptor mediated effects: role of androgens. Neurosci Biobehav Rev 2022;134:104522.

    OpenUrlCrossRef
21. 21.↵
    1. Huhn AS,
    2. Berry MS,
    3. Dunn KE

    . Systematic review of sex-based differences in opioid-based effects. International Review of Psychiatry 2018;30:107–16.

    OpenUrlCrossRef
22. 22.↵
    1. Alabas O,
    2. Tashani O,
    3. Tabasam G,
    4. Johnson M

    . Gender role affects experimental pain responses: a systematic review with meta‐analysis. European Journal of Pain 2012;16:1211–23.

    OpenUrl
23. 23.↵
    1. Dowell D,
    2. Ragan KR,
    3. Jones CM,
    4. Baldwin GT,
    5. Chou R

    . CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep 2022;71:1–95.

    OpenUrl
24. 24.↵
    1. James JR,
    2. Scott JM,
    3. Klein JW,
    4. et al

    . Mortality after discontinuation of primary care–based chronic opioid therapy for pain: a retrospective cohort study. J Gen Intern Med 2019;34:2749–55.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Auty SG,
    2. Barr KD,
    3. Frakt AB,
    4. Garrido MM,
    5. Strombotne KL

    . Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Addiction 2023;118(5):870–879.

    OpenUrl
26. 26.↵
    1. Manhapra A,
    2. Sullivan MD,
    3. Ballantyne JC,
    4. MacLean RR,
    5. Becker WC

    . Complex persistent opioid dependence with long-term opioids: a gray area that needs definition, better understanding, treatment guidance, and policy changes. J Gen Intern Med 2020;35:964–71.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Hasin DS,
    2. Shmulewitz D,
    3. Stohl M,
    4. et al

    . Diagnosing prescription opioid use disorder in patients using prescribed opioids for chronic pain. AJP 2022;179:715–25.

    OpenUrl